Description

{“@context”:”https://schema.org”,”@type”:”FAQPage”,”mainEntity”:[
{“@type”:”Question”,”name”:”What research class does GLP2-T belong to?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”GLP2-T is studied as a dual-agonist research peptide (tirzepatide-class) targeting GLP-1 and GIP receptors in laboratory metabolic research.”}},
{“@type”:”Question”,”name”:”What purity is the GLP2-T sold by Pure Chain Aminos?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”Every GLP2-T batch ships with a third-party Certificate of Analysis verifying HPLC purity (typically >98%) and mass-spectrometry identity confirmation.”}},
{“@type”:”Question”,”name”:”Does the GLP2-T 30mg vial ship with a Certificate of Analysis?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”Yes. Every batch ships with a third-party Certificate of Analysis verifying HPLC purity and mass-spectrometry identity confirmation.”}},
{“@type”:”Question”,”name”:”What is the typical reconstitution volume for the GLP2-T 30mg vial?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”Researchers typically reconstitute the 30mg vial with 3-5 mL of bacteriostatic water depending on study protocol. See the bacteriostatic water reconstitution guide at https://purechainaminos.com/bacteriostatic-water-reconstitution-guide/ for laboratory reference.”}},
{“@type”:”Question”,”name”:”How is GLP2-T stored before reconstitution?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”Lyophilized vials store at 2-8°C. Reconstituted solution refrigerate immediately and reference batch COA for product-specific stability data.”}},
{“@type”:”Question”,”name”:”Is GLP2-T sold for human use?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”All research peptides sold by Pure Chain Aminos are for laboratory research use only. Not approved by the FDA, not for human consumption.”}},
{“@type”:”Question”,”name”:”How does GLP2-T differ from GLP3-R in laboratory research?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”GLP2-T is studied as a dual-agonist research peptide (tirzepatide-class) targeting two receptors, while GLP3-R is studied as a triple-agonist research peptide (retatrutide-class) targeting three. See the GLP2-T vs GLP3-R research comparison article for details.”}}
]}